title: Hypogonadism related to crizotinib therapy: implications for patient care.
authors.forename: Suresh S
authors.initials: SS
authors.lastname: Ramalingam
authors.forename: Alice T
authors.initials: AT
authors.lastname: Shaw
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D000077547:Crizotinib; D006801:Humans; D007006:Hypogonadism / Q000139:chemically induced*; D008297:Male; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011720:Pyrazoles / Q000009:adverse effects*; D011725:Pyridines / Q000009:adverse effects*; D013739:Testosterone / Q000097:blood*
chemical_list: D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D011720:Pyrazoles; D011725:Pyridines; D013739:Testosterone; D000077547:Crizotinib